Image Source: Unsplash
Biotech Momentum Is Picking Up
Earlier in 2023 we had a nice run in SMID biotech stocks. Most have since sold off but now we seem poised for a rally. We updated our WATCH list from earlier this year. Unless your healthcare portfolio was overweight large cap biopharma including Lilly or NVO you are underperforming the market. Healthcare and Bioscience Mutual Funds are trailing the S&P-500 and the Dow. ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.I will add new trades as they come up should market conditions look favorable.Here are some assumptions for trading in Small Cap speculative biotech.
More By This Author:Risk On For Biotech – Time To Trade The Small Caps
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield…